home *** CD-ROM | disk | FTP | other *** search
- TABLE 18-11. mAb-Defined TAA Utilized as Markers or Targets in
- Clinical Trials
-
- (Ferrone S, Chu T, Hellstrom KE. Tumor antigens recognized by
- monoclonal antibodies. In: DeVita VT, Hellman S, Rosenberg SA, eds.
- Biologic therapy of cancer, ed 2. Philadelphia: Lippincott-Raven,
- 1995:77)
-